BUDD LAKE, NJ, Jan. 03, 2025 (GLOBE NEWSWIRE) -- EMCORE Corporation (Nasdaq: EMKR), a leading provider of inertial navigation solutions to the aerospace and defense industry, today announced results for the fiscal 2024 fourth quarter (4Q24) ended September 30, 2024.
"As we close out the fiscal year, we are pleased to report that execution on our previously announced restructuring plan resulted in significant progress in all areas of the business. During 4Q24, the Company generated positive cash flow of $1.8 million and substantially lowered operating expenses," said Matt Vargas, interim Chief Executive Officer. "In addition, on a sequential-quarter basis, we increased revenue 6% and grew backlog on the strength of continued strong bookings during 4Q24."
Three Months Ended | |||||||||
Sep 30, 2024 | Jun 30, 2024 | +increase/ -decrease | |||||||
4Q24 | 3Q24 | ||||||||
Revenue | $21.7M | $20.4M | +$1.3M | ||||||
Gross margin | 21% | 25% | -4% | ||||||
Operating expenses | $7.8M | $14.3M | -$6.5M | ||||||
Net loss on continuing operations | ($3.2M) | ($11.5M) | +$8.3M | ||||||
Net loss on continuing operations per share, basic and diluted | ($0.35) | ($1.27) | +$0.92 | ||||||
Non-GAAP gross margin (a) | 23% | 24% | -1% | ||||||
Non-GAAP operating expenses (a) | $6.1M | $9.1M | -$3.0M | ||||||
Non-GAAP net loss on continuing operations (a) | ($2.0M) | ($4.4M) | +$2.4M | ||||||
Non-GAAP net loss on continuing operations per share, basic and diluted (a) | ($0.22) | ($0.49) | +$0.27 | ||||||
Adjusted EBITDA (a) | ($0.4M) | ($3.6M) | +$3.2M | ||||||
Cash and cash equivalents at end of period | $10.8M | $9.0M | +$1.8M | ||||||
Line of credit and loan payable (b) | $0.0M | $8.4M | -$8.4M | ||||||
(a) Please refer to the schedules at the end of this press release for GAAP to non-GAAP reconciliations and other information related to non-GAAP financial measures. (b) 4Q24 includes loan payoff totaling $8.4 million. |
About EMCORE
EMCORE Corporation is a leading provider of inertial navigation solutions to the aerospace and defense markets. We leverage industry-leading Photonic Integrated Chip (PIC), Quartz MEMS, and Lithium Niobate chip-level technology to deliver state-of-the-art component and system-level products across our end-market applications. EMCORE has vertically-integrated manufacturing capability at its facilities in Budd Lake, NJ, Concord, CA, and Tinley Park, IL. Our manufacturing facilities all maintain ISO 9001 quality management certification, and we are AS9100 aerospace quality certified at our facilities in Budd Lake and Concord. For further information about EMCORE, please visit https://www.emcore.com.
Use of Non-GAAP Financial Measures
The Company conforms to U.S. Generally Accepted Accounting Principles ("GAAP") in the preparation of its financial statements. We disclose supplemental non-GAAP earnings measures, including for gross profit, gross margin, operating expenses, net loss, net loss per share, and adjusted EBITDA. The Company has, regardless of result, applied consistent rationale and methods when presenting supplemental non-GAAP measures.
Management believes these supplemental non-GAAP measures reflect the Company's core ongoing operating performance and facilitate comparisons across reporting periods. The Company uses these measures when evaluating its financial results and for planning and forecasting of future periods. We believe that these supplemental non-GAAP measures are also useful to investors in assessing our operating performance. While we believe in the usefulness of these supplemental non-GAAP measures, there are limitations. Our non-GAAP measures may not be reported by other companies in our industry and/or may not be directly comparable to similarly titled measures of other companies due to potential differences in calculation. We compensate for these limitations by using these non-GAAP measures as a supplement to GAAP and by providing the reconciliations to the most comparable GAAP measure.
The schedules at the end of this press release reconcile the Company's non-GAAP measures to the most directly comparable GAAP measure. The adjustments share one or more of the following characteristics: (a) they are unusual and the Company does not expect them to recur in the ordinary course of its business, (b) they do not involve the expenditure of cash, (c) they are unrelated to the ongoing operation of the business in the ordinary course, or (d) their magnitude and timing is largely outside of the Company's control. All of these items meet one or more of the characteristics listed above. The criteria that must be met for litigation-related expense to qualify as a non-GAAP measure is that it must be directly connected to active litigation that the Company infrequently encounters and is unrelated to the ongoing operations of the business in the ordinary course. All legal expenses related to the ordinary course of business are included in the non-GAAP results consistently for all reporting periods. The Company has, for all reporting periods disclosed in this press release, applied consistent rationale, method, and adjustments in reconciling non-GAAP measures to the most directly comparable GAAP measure, reflecting the Company's core ongoing operating performance and facilitating comparisons across reporting periods that the Company uses when evaluating its financial results, planning and forecasting future periods, and that are useful to investors in assessing our performance.
Non-GAAP measures are not in accordance with or an alternative to GAAP, nor are they meant to be considered in isolation or as a substitute for comparable GAAP measures. Our disclosures of these measures should be read only in conjunction with our financial statements prepared in accordance with GAAP. Non-GAAP measures should not be viewed as a substitute for the Company's GAAP results.
EMCORE CORPORATION Consolidated Balance Sheets (unaudited) | |||||||
September 30, | September 30, | ||||||
(in thousands) | 2024 | 2023 | |||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 10,291 | $ | 26,211 | |||
Restricted cash | 495 | 495 | |||||
Accounts receivable, net of credit loss of $173 and $356, respectively | 14,342 | 15,575 | |||||
Contract assets | 1,182 | 8,402 | |||||
Inventory | 25,065 | 28,905 | |||||
Prepaid expenses | 3,504 | 4,612 | |||||
Other current assets | 137 | 922 | |||||
Assets held for sale | - | 7,264 | |||||
Total current assets | 55,016 | 92,386 | |||||
Property, plant, and equipment, net | 7,868 | 15,517 | |||||
Operating lease right-of-use assets | 18,094 | 21,564 | |||||
Other intangible assets, net | 10,289 | 12,245 | |||||
Other non-current assets | 2,646 | 2,201 | |||||
Total assets | $ | 93,913 | $ | 143,913 | |||
LIABILITIES and SHAREHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 8,563 | $ | 9,683 | |||
Accrued expenses and other current liabilities | 5,220 | 8,471 | |||||
Contract liabilities | 1,424 | 1,630 | |||||
Loan payable - current | - | 852 | |||||
Financing payable | 587 | 460 | |||||
Loan payable - current | - | 852 | |||||
Operating lease liabilities - current | 2,668 | 3,033 | |||||
Liabilities held for sale | - | 4,662 | |||||
Total current liabilities | 18,462 | 28,791 | |||||
Line of credit | - | 6,418 | |||||
Loan payable - non-current | - | 3,330 | |||||
Operating lease liabilities - non-current | 18,247 | 20,882 | |||||
Asset retirement obligations | 2,378 | 4,194 | |||||
Warrant liability and other long-term liabilities | 4,660 | 8 | |||||
Total liabilities | 43,747 | 63,623 | |||||
Commitments and contingencies | |||||||
Shareholders' equity: | |||||||
Common stock, no par value, 100,000 shares authorized; 9,764 shares issued and 9,073 shares outstanding as of September 30, 2024; 8,401 shares issued and 7,711 shares outstanding as of September 30, 2023 | 825,625 | 825,119 | |||||
Treasury stock at cost; 691 shares as of September 30, 2024 and September 30, 2023 | (47,721 | ) | (47,721 | ) | |||
Accumulated other comprehensive income | 958 | 350 | |||||
Accumulated deficit | (728,696 | ) | (697,458 | ) | |||
Total shareholders' equity | 50,166 | 80,290 | |||||
Total liabilities and shareholders' equity | $ | 93,913 | $ | 143,913 |
EMCORE CORPORATION Consolidated Statements of Operations (unaudited) | |||||||||||||||
Three Months Ended September 30, | Fiscal Year Ended September 30, | ||||||||||||||
(in thousands, except for per share data) | 2024 | 2023 | 2024 | 2023 | |||||||||||
Revenue | $ | 21,704 | $ | 26,769 | $ | 85,896 | $ | 97,716 | |||||||
Cost of revenue | 17,232 | 19,876 | 67,076 | 74,323 | |||||||||||
Gross profit | 4,472 | 6,893 | 18,820 | 23,393 | |||||||||||
Operating expense: | |||||||||||||||
Selling, general, and administrative | 5,011 | 8,638 | 22,281 | 32,731 | |||||||||||
Research and development | 2,057 | 4,468 | 12,922 | 17,910 | |||||||||||
Restructuring | 872 | - | 2,219 | - | |||||||||||
Severance | (168 | ) | - | 2,919 | 27 | ||||||||||
Impairment | 3 | 22,612 | 3,010 | 22,612 | |||||||||||
Loss (gain) on sale of assets | 50 | - | 18 | (1,147 | ) | ||||||||||
Total operating expense | 7,825 | 35,718 | 43,369 | 72,133 | |||||||||||
Operating loss | (3,353 | ) | (28,825 | ) | (24,549 | ) | (48,740 | ) | |||||||
Other income (expense): | |||||||||||||||
Loss on extinguishment of debt and change in fair value of warrant liability | (2,572 | ) | - | (4,660 | ) | - | |||||||||
Interest expense, net | (940 | ) | (147 | ) | (1,195 | ) | (751 | ) | |||||||
Other income (expense) | 3,612 | (9 | ) | 3,581 | 120 | ||||||||||
Total other income (expense) | 100 | (156 | ) | (2,274 | ) | (631 | ) | ||||||||
Loss from continuing operations before income tax benefit (expense) | (3,253 | ) | (28,981 | ) | (26,823 | ) | (49,371 | ) | |||||||
Income tax benefit (expense) from continuing operations | 85 | 135 | (29 | ) | (42 | ) | |||||||||
Net loss from continuing operations | $ | (3,168 | ) | $ | (28,846 | ) | $ | (26,852 | ) | $ | (49,413 | ) | |||
Income (loss) from discontinued operations | $ | 63 | $ | (12,735 | ) | $ | (4,386 | ) | $ | (25,946 | ) | ||||
Net loss | $ | (3,105 | ) | $ | (41,581 | ) | $ | (31,238 | ) | $ | (75,359 | ) | |||
Pension adjustment | 608 | (91 | ) | 608 | (91 | ) | |||||||||
Comprehensive loss | $ | (2,497 | ) | $ | (41,672 | ) | $ | (30,630 | ) | $ | (75,450 | ) | |||
Per share data: | |||||||||||||||
Net loss on continuing operations per share, basic and diluted | $ | (0.35 | ) | $ | (0.42 | ) | $ | (2.98 | ) | $ | (0.96 | ) | |||
Net income (loss) on discontinued operations per share, basic and diluted | $ | 0.01 | $ | (0.18 | ) | $ | (0.49 | ) | $ | (0.50 | ) | ||||
Net loss per share, basic and diluted | $ | (0.34 | ) | $ | (0.60 | ) | $ | (3.46 | ) | $ | (1.46 | ) | |||
Weighted-average number of shares outstanding, basic and diluted | 9,063 | 69,209 | 9,020 | 51,510 |
EMCORE CORPORATION Reconciliations of GAAP to Non-GAAP Financial Measures (unaudited) | |||||||
Three Months Ended | |||||||
September 30 | June 30 | ||||||
(in thousands, except for percentages) | 4Q24 | 3Q24 | |||||
Gross profit | $ | 4,472 | $ | 5,013 | |||
Gross margin | 21 | % | 25 | % | |||
Stock-based compensation expense | 40 | 70 | |||||
Asset retirement obligation accretion | 61 | 61 | |||||
Intangible asset amortization | 482 | 486 | |||||
Compensation accrual adjustment | - | (806 | ) | ||||
Non-GAAP gross profit | $ | 5,055 | $ | 4,824 | |||
Non-GAAP gross margin | 23 | % | 24 | % |
Three Months Ended | |||||||
September 30 | June 30 | ||||||
(in thousands) | 4Q24 | 3Q24 | |||||
Operating expense | $ | 7,825 | $ | 14,276 | |||
Stock-based compensation expense | (359 | ) | 1,182 | ||||
Impairment expense | (3 | ) | (2,919 | ) | |||
Severance expense | 168 | (1,856 | ) | ||||
Restructuring expense | (872 | ) | (1,347 | ) | |||
Loss on sale of assets | (50 | ) | - | ||||
Compensation accrual adjustment | - | 506 | |||||
Transition/M&A-related expense | (598 | ) | (615 | ) | |||
Litigation-related expense | (39 | ) | (156 | ) | |||
Non-GAAP operating expense | $ | 6,072 | $ | 9,071 |
Three Months Ended | |||||||
September 30 | June 30 | ||||||
(in thousands, except for per share data and percentages) | 4Q24 | 3Q24 | |||||
Net loss from continuing operations | $ | (3,168 | ) | $ | (11,545 | ) | |
Net loss from continuing operations per share, basic and diluted | $ | (0.35 | ) | $ | (1.27 | ) | |
Stock-based compensation expense | 399 | (1,112 | ) | ||||
Asset retirement obligation accretion | 61 | 61 | |||||
Intangible asset amortization | 482 | 486 | |||||
Impairment expense | 3 | 2,919 | |||||
Severance expense | (168 | ) | 1,856 | ||||
Restructuring expense | 872 | 1,347 | |||||
Loss on sale of assets | 50 | - | |||||
Compensation accrual adjustment | - | (1,312 | ) | ||||
Transition/M&A-related expense | 598 | 615 | |||||
Litigation-related expense | 39 | 156 | |||||
Loss on extinguishment of debt and change in fair value of warrant liability | 2,572 | 2,087 | |||||
Other (income) expense | (3,612 | ) | 16 | ||||
Income tax benefit | (85 | ) | - | ||||
Non-GAAP net loss from continuing operations | $ | (1,957 | ) | $ | (4,426 | ) | |
Non-GAAP net loss from continuing operations per share, basic and diluted | $ | (0.22 | ) | $ | (0.49 | ) | |
Interest expense, net | 940 | 179 | |||||
Depreciation expense | 580 | 670 | |||||
Adjusted EBITDA | $ | (437 | ) | $ | (3,577 | ) | |
Adjusted EBITDA % of revenue | (2.0 | %) | (18 | %) |